QUOTE OF THE DAY
QUICKLINKS AND VIEW OPITONS
SUMMARY VIEW
NEW! Page 1 of 1. Go to page
Wednesday, October 28, 2009
ZYPREXA
Children and adolescents given Abilify gained an average of 9.7 lbs in 3 months
Children and adolescents, 4- to 19-years-old, given Abilify (aripiprazole) gained an average of 11.7 lbs in less than 3 months (11 weeks) according to a new study published in JAMA.
Read the entire article | Email this article
Thursday, December 27, 2007
ZYPREXA, GEODON & ABILIFY
‘I gained 70 lbs while taking Zyprexa,’ said P. Wagner, ‘but stopped eating on Geodon plus Abilify’
Here is a fascinating story about a person named P. Wagner who who could not stop eating when taking Zyprexa and gained 70 pounds, but then lost a tremendous amount of weight when switched to Geodon combined with Abilify.
Read the entire article | Email this article
Saturday, July 09, 2005
Chart comparing weight gain from antipsychotic drugs
Below is a chart comparing weight gain during the first two-and-a-half months from various antipsychotic drugs.
Read the entire article | Email this article
Thursday, April 14, 2005
ANTIPSYCHOTIC DRUGS
Antipsychotic drugs associated with weight gains of 2 to 22 pounds
Many antipsychotic drugs are associated with weight gain. Solian (amisulpride), Geodon (ziprasidone), and Abilify (aripiprazole) are associated with weight gains of less than 4.4 pounds, however, Zyprexa (olanzapine) has been associated with a large weight gain of between 8.8 and 22 pounds according to a paper from Washington University School of Medicine in St. Louis, Missouri.
Read the entire article | Email this article
Wednesday, January 05, 2005
DRUGS FOR SCHIZOPHRENIA
Drugs for schizophrenia: Abilify (aripiprazole) causes weight loss, Zyprexa (olanzapine) weight gain
Schizophrenic patients given Abilify (aripiprazole) lost 3 pounds in six months compared to a weight gain of 9.4 pounds in patients given Zyprexa (olanzapine) according to a new study.
Read the entire article | Email this article
© Copyright 2003-2009 - Larry Hobbs - All Rights Reserved.